Dr Reddy's launches Remdesivir for COVID-19 treatment in India

Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India

Dr Reddy's launches Remdesivir for COVID-19 treatment in India

Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India

Hyderabad, September 9

Dr Reddys Laboratories Ltd on Wednesday announced the launch of Remdesivir, meant for the treatment of COVID-19 patients, under a brand name 'Redyx' in India.

According to a press release from the drug maker, the launch is part of the licensing agreement with Gilead Sciences, Inc. (Gilead) that grants Dr Reddys the right to register, manufacture and sell Remdesivir, a potential treatment for Covid-19, in 127 countries including India.

Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of Covid-19 patients hospitalized with severe symptoms.

"Dr Reddy's Redyx is available in strength of 100 mg vial," it said.

Chief Executive Officer of Branded Markets (India and Emerging Markets), Dr Reddys Laboratories, M V Ramana said, "We will continue our efforts to develop products that address significant unmet needs of patients.

The launch of Redyx reaffirms our commitment to bringing in critical medicine for patients suffering from COVID-19 in India." PTI

Top Stories

India, US ink military pact, set stage for expanding collaboration

India, US ink military pact, set stage for expanding collaboration

Trade, people-to-people ties remain in limbo; more tie-ups i...

Govt paves way for all Indians to buy land in Jammu and Kashmir

Govt paves way for all Indians to buy land in Jammu and Kashmir

Union Home Ministry repeals 12 laws enacted by the erstwhile...

India declares 18 Pakistan-based individuals as designated terrorists under UAPA

India declares 18 Pakistan-based individuals as designated terrorists under UAPA

The list issued by the MHA has names of Chhota Shakeel, Bhat...

Facebook India’s Ankhi Das steps down to pursue 'public service'

Facebook India’s Ankhi Das steps down to pursue 'public service'

Comes two months after allegations that she stopped company ...

Cities

View All